Leeward Investments LLC MA Has $17.14 Million Stock Position in Leidos Holdings, Inc. (NYSE:LDOS)

Leeward Investments LLC MA lowered its stake in Leidos Holdings, Inc. (NYSE:LDOS) by 2.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 158,366 shares of the aerospace company’s stock after selling 4,280 shares during the quarter. Leeward Investments LLC MA owned about 0.12% of Leidos worth $17,142,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. Wellington Management Group LLP raised its stake in shares of Leidos by 6.2% in the 3rd quarter. Wellington Management Group LLP now owns 4,660,386 shares of the aerospace company’s stock valued at $429,501,000 after purchasing an additional 272,090 shares during the period. Massachusetts Financial Services Co. MA raised its stake in shares of Leidos by 5.9% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,044,206 shares of the aerospace company’s stock valued at $280,554,000 after purchasing an additional 169,351 shares during the period. FMR LLC raised its stake in shares of Leidos by 36.1% in the 3rd quarter. FMR LLC now owns 1,808,666 shares of the aerospace company’s stock valued at $166,687,000 after purchasing an additional 479,906 shares during the period. Pzena Investment Management LLC raised its stake in shares of Leidos by 320.1% in the 3rd quarter. Pzena Investment Management LLC now owns 1,246,768 shares of the aerospace company’s stock valued at $114,902,000 after purchasing an additional 949,955 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Leidos by 1.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,161,653 shares of the aerospace company’s stock valued at $107,058,000 after purchasing an additional 16,250 shares during the period. Institutional investors and hedge funds own 76.12% of the company’s stock.

Leidos Stock Up 0.3 %

LDOS opened at $130.33 on Friday. Leidos Holdings, Inc. has a 12 month low of $76.58 and a 12 month high of $131.50. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 1.10. The company has a market cap of $17.61 billion, a PE ratio of 91.78, a price-to-earnings-growth ratio of 1.79 and a beta of 0.70. The company has a 50 day moving average of $127.59 and a 200 day moving average of $113.69.

Leidos (NYSE:LDOS) last posted its quarterly earnings data on Tuesday, February 13th. The aerospace company reported $1.99 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.25. The firm had revenue of $3.98 billion for the quarter, compared to analysts’ expectations of $3.81 billion. Leidos had a net margin of 1.29% and a return on equity of 22.92%. The business’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter last year, the company posted $1.83 EPS. On average, sell-side analysts expect that Leidos Holdings, Inc. will post 7.77 EPS for the current year.

Leidos Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, May 28th. Shareholders of record on Tuesday, May 14th will be issued a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a yield of 1.17%. Leidos’s dividend payout ratio (DPR) is presently 107.04%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on LDOS shares. Royal Bank of Canada raised their price objective on Leidos from $105.00 to $120.00 and gave the company a “sector perform” rating in a report on Wednesday, February 14th. Jefferies Financial Group raised their price objective on Leidos from $130.00 to $135.00 and gave the company a “hold” rating in a report on Wednesday, April 10th. StockNews.com cut Leidos from a “strong-buy” rating to a “buy” rating in a report on Friday. Truist Financial lifted their price target on Leidos from $135.00 to $150.00 and gave the stock a “buy” rating in a report on Tuesday, April 9th. Finally, Robert W. Baird lifted their price target on Leidos from $133.00 to $145.00 and gave the stock an “outperform” rating in a report on Wednesday, February 14th. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $132.42.

Insiders Place Their Bets

In other Leidos news, Director David G. Fubini sold 7,874 shares of the firm’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $127.89, for a total value of $1,007,005.86. Following the sale, the director now owns 14,696 shares of the company’s stock, valued at approximately $1,879,471.44. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, Director Gary Stephen May sold 2,745 shares of the business’s stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $124.49, for a total transaction of $341,725.05. Following the sale, the director now owns 11,352 shares of the company’s stock, valued at $1,413,210.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director David G. Fubini sold 7,874 shares of the business’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $127.89, for a total transaction of $1,007,005.86. Following the sale, the director now directly owns 14,696 shares in the company, valued at approximately $1,879,471.44. The disclosure for this sale can be found here. Insiders own 0.96% of the company’s stock.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.